WuXi Biologics
Offering End-to-End Solutions
Modalities
Overview
WuXi Vaccines provides comprehensive CMC development and GMP manufacturing services for a wide range of modalities produced from microbial-based production systems. As a world-leading Contract Development and Manufacturing Organization (CDMO), we established world-class facilities and a highly-trained team of experts to provide end-to-end services from strain development to regulatory filing and beyond. Leveraging these technical capabilities along with our highly efficient project management systems, we are able to greatly expedite product development to bring critical vaccines into the clinic and on to the market.
Comprehensive Range of Supported Product Modalities
We support an array of prophylactic products produced via microbial fermentation which include recombinant proteins (e.g., subunit vaccines), virus-like particles (VLP) or nucleic acid-based vaccines. Our support includes production of GMP-grade plasmid DNA that may be required directly as vaccines or for mRNA vaccine programs. Our integrated service offerings include comprehensive cell line/strain development, process development, analytical, formulation, and drug product development, as well as Drug Substance (DS) and Drug Product (DP) GMP manufacturing.
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?